In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...

Piper Sandler analyst David Westenberg maintained a Hold rating on Tempus AI, Inc. Class A (TEM – Research Report) today and set a price target ...

Scotiabank analyst Patrick Colville maintained a Hold rating on Okta (OKTA – Research Report) today and set a price target of $109.00. The ...

Research analysts at StockNews.com started coverage on shares of Provident Financial (NASDAQ:PROV – Get Free Report) in a note issued to investors on Sunday. The firm set a “hold” rating on the ...

Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and ...

Pliant Therapeutics (PLRX – Research Report) received a Hold rating and price target from Needham analyst Joseph Stringer today. The ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Pliant Therapeutics (PLRX – Research Report) yesterday and set a price target of ...

StockNews.com upgraded shares of First Internet Bancorp (NASDAQ:INBK – Free Report) from a hold rating to a buy rating in a report published on Monday morning. INBK has been the subject of a number of ...

Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine brokerages ...

StockNews.com upgraded shares of Virtus Investment Partners (NASDAQ:VRTS – Free Report) from a hold rating to a buy rating in a report published on Monday morning. A number of other equities research ...

Equities researchers at Leerink Partnrs issued their Q1 2025 EPS estimates for argenx in a research report issued to clients ...